Barbara Peil

1.8k total citations
22 papers, 454 citations indexed

About

Barbara Peil is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Barbara Peil has authored 22 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Barbara Peil's work include Diabetes Treatment and Management (5 papers), Cardiovascular Function and Risk Factors (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Barbara Peil is often cited by papers focused on Diabetes Treatment and Management (5 papers), Cardiovascular Function and Risk Factors (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Barbara Peil collaborates with scholars based in Germany, United States and France. Barbara Peil's co-authors include Hubertus Peil, Bernhard Aicher, HC Diener, Cordula Zeller, Piotr Ponikowski, Javed Butler, Muhammad Shahzeb Khan, Gerasimos Filippatos, Martina Brueckmann and Waheed Jamal and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Barbara Peil

22 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Peil Germany 10 145 130 83 82 79 22 454
Charlotte van Noord Netherlands 13 270 1.9× 137 1.1× 70 0.8× 94 1.1× 119 1.5× 32 607
Frank T. Spradley United States 19 164 1.1× 66 0.5× 60 0.7× 71 0.9× 110 1.4× 58 1.4k
Sabine Wessels Germany 9 203 1.4× 85 0.7× 107 1.3× 55 0.7× 61 0.8× 9 586
Almira Babovic Norway 7 136 0.9× 212 1.6× 76 0.9× 96 1.2× 32 0.4× 10 425
Caroline Demacq Brazil 13 295 2.0× 107 0.8× 40 0.5× 83 1.0× 52 0.7× 25 594
Robert R. Henry United States 8 209 1.4× 230 1.8× 37 0.4× 108 1.3× 143 1.8× 8 544
Alan Sacerdote United States 10 75 0.5× 190 1.5× 31 0.4× 55 0.7× 74 0.9× 24 423
Takashi Nakagawa Japan 15 306 2.1× 49 0.4× 106 1.3× 80 1.0× 72 0.9× 54 673
Gerong Qin Denmark 9 102 0.7× 282 2.2× 51 0.6× 101 1.2× 88 1.1× 10 726
Neville Jackson United Kingdom 7 189 1.3× 135 1.0× 94 1.1× 42 0.5× 53 0.7× 12 445

Countries citing papers authored by Barbara Peil

Since Specialization
Citations

This map shows the geographic impact of Barbara Peil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Peil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Peil more than expected).

Fields of papers citing papers by Barbara Peil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Peil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Peil. The network helps show where Barbara Peil may publish in the future.

Co-authorship network of co-authors of Barbara Peil

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Peil. A scholar is included among the top collaborators of Barbara Peil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Peil. Barbara Peil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Muhammad Shahzeb, Stefan D. Anker, Gerasimos Filippatos, et al.. (2023). Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial. Journal of Cardiac Failure. 29(10). 1345–1354. 1 indexed citations
2.
Bianzano, Susanna, Matias Nordaby, Leona Plum‐Mörschel, Barbara Peil, & Tim Heise. (2022). Safety, tolerability, pharmacodynamics and pharmacokinetics following once‐daily doses of BI 187004, an inhibitor of 11 beta‐hydroxysteroid dehydrogenase‐1, over 28 days in patients with type 2 diabetes mellitus and overweight or obesity. Diabetes Obesity and Metabolism. 25(3). 832–843. 6 indexed citations
3.
Butler, Javed, Muhammad Shahzeb Khan, JoAnn Lindenfeld, et al.. (2022). Minimally Clinically Important Difference in Health Status Scores in Patients With HFrEF vs HFpEF. JACC Heart Failure. 10(9). 651–661. 20 indexed citations
4.
Anker, Stefan D., Muhammad Shahzeb Khan, Javed Butler, et al.. (2022). Weight Change and Clinical Outcomes in Heart Failure with Reduced Ejection Fraction: Insights from EMPEROR-Reduced. European Journal of Heart Failure. 25(1). 117–127. 36 indexed citations
5.
Butler, Javed, Stefan D. Anker, Gerasimos Filippatos, et al.. (2020). Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial. European Heart Journal. 42(13). 1203–1212. 110 indexed citations
6.
Predel, Hans‐Georg, Caty Ebel‐Bitoun, Barbara Peil, Thomas Weiser, & Robert Lange. (2020). Efficacy and Safety of Diclofenac + Capsaicin Gel in Patients with Acute Back/Neck Pain: A Multicenter Randomized Controlled Study. SHILAP Revista de lepidopterología. 9(1). 279–296. 13 indexed citations
7.
Lenz, Heinz‐Josef, Guillem Argilés, Takayuki Yoshino, et al.. (2019). Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses. Clinical Colorectal Cancer. 18(4). 269–279.e5. 6 indexed citations
8.
Abraham, William T., Piotr Ponikowski, Martina Brueckmann, et al.. (2019). Rationale and Design of The Emperial-Preserved and Emperial-Reduced Trials of Empagliflozin in Patients with Chronic Heart Failure. European Journal of Heart Failure. 21(7). 932–942. 38 indexed citations
9.
10.
Lü, Shun, Wěi Li, Caicun Zhou, et al.. (2018). Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung. OncoTargets and Therapy. Volume 11. 8565–8573. 7 indexed citations
11.
Park, Keunchil, Eng Huat Tan, Li Zhang, et al.. (2017). P3.02b-044 Afatinib versus Gefitinib as First-Line Treatment for EGFR Mutation-Positive NSCLC Patients Aged ≥75 Years: Subgroup Analysis of LUX-Lung 7. Journal of Thoracic Oncology. 12(1). S1214–S1214. 1 indexed citations
12.
Sequist, Lecia V., Yi‐Long Wu, Martin Schüler, et al.. (2017). Subsequent therapies post-afatinib among patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC in LUX-Lung (LL) 3, 6 and 7. Annals of Oncology. 28. v482–v483. 10 indexed citations
13.
14.
15.
Kesselmeier, Miriam, Carine Legrand, Barbara Peil, et al.. (2014). Practical investigation of the performance of robust logistic regression to predict the genetic risk of hypertension. BMC Proceedings. 8(S1). S65–S65. 5 indexed citations
16.
Haas, Jan, Feng Zhu, Christian Geier, et al.. (2014). Abstract 17517: Genetics of Left Ventricular Noncompaction Cardiomyopathy. Circulation. 130(suppl_2). 1 indexed citations
17.
Peil, Barbara, Maria Kabisch, Christine Fischer, Ute Hamann, & Justo Lorenzo Bermejo. (2014). Tailored Selection of Study Individuals to be Sequenced in Order to Improve the Accuracy of Genotype Imputation. Genetic Epidemiology. 39(2). 114–121. 3 indexed citations
18.
Scherf, David, Rainer Claus, Justo Lorenzo Bermejo, et al.. (2012). Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4. Oncogene. 32(28). 3329–3338. 29 indexed citations
19.
Aicher, Bernhard, Hubertus Peil, Barbara Peil, & H.C. Diener. (2012). Pain measurement: Visual Analogue Scale (VAS) and Verbal Rating Scale (VRS) in clinical trials with OTC analgesics in headache. Cephalalgia. 32(3). 185–197. 17 indexed citations
20.
Aicher, Bernhard, Hubertus Peil, Barbara Peil, & HC Diener. (2011). Pain measurement: Visual Analogue Scale (VAS) and Verbal Rating Scale (VRS) in clinical trials with OTC analgesics in headache. Cephalalgia. 32(3). 185–197. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charlotte van Noord Breakdown of academic impact, for papers by Frank T. Spradley Breakdown of academic impact, for papers by Sabine Wessels Breakdown of academic impact, for papers by Almira Babovic Breakdown of academic impact, for papers by Caroline Demacq Breakdown of academic impact, for papers by Robert R. Henry Breakdown of academic impact, for papers by Alan Sacerdote Breakdown of academic impact, for papers by Takashi Nakagawa Breakdown of academic impact, for papers by Gerong Qin Breakdown of academic impact, for papers by Neville Jackson
Rankless by CCL
2026